Taís Nóbrega de Sousa

Publications
Public outreach and news

Articles

Article: INFECTION GENETICS AND EVOLUTION. 2024;123:105628

Natural genetic diversity of the DBL domain of a novel member of the Plasmodium vivax erythrocyte binding-like proteins (EBP2) in the Amazon rainforest

Fernandes GM; Rodrigues-Mattos GH; Torres LM; Guedes KS; Fontes CJF; Ntumngia FB; Adams JH; Brito CFA; Kano FS; de Sousa TN; Carvalho LH
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024;79(8):1985-1989

Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.

Puça MCSDB; Rodrigues DF; Salazar YEAR; Louzada J; Fontes CJF; Daher A; Pereira DB; Fernandes Vieira JL; Carvalho LH; Alves de Brito CF; Gil JP; Nobrega de Sousa T
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2024;68(5):e01390-e01323

Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy

Camara MD; Zhou Y; Dara A; Tekete MM; de Sousa TN; Sissoko S; Dembele L; Ouologuem N; Togo AH; Alhousseini ML; Fofana B; Sagara I; Djimde AA; Gil PJ; Lauschke VM
Article: HUMAN GENOMICS. 2024;18(1):40

Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences

Camara MD; Zhou Y; De Sousa TN; Gil JP; Djimde AA; Lauschke VM
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2024;68(4):e01204-e01223

Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR).

Salazar YEAR; Louzada J; Puça MCSDB; Guimarães LFF; Vieira JLF; Siqueira AMD; Gil JP; Brito CFAD; Sousa TND
Article: INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE. 2021;15:9-24

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions.

Ferreira MU; Nobrega de Sousa T; Rangel GW; Johansen IC; Corder RM; Ladeia-Andrade S; Gil JP

All other publications

Review: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2022;18(1):39-59

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

Pernaute-Lau L; Camara M; de Sousa TN; Morris U; Ferreira MU; Gil JP

Articles

All other publications

News from KI

Events from KI